Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.
Event:
Heart Failure 2023
Topic:
Hypertrophic Cardiomyopathy
Session:
Myocardial disease - hypertrophic cardiomyopathy 3
